230 related articles for article (PubMed ID: 37324256)
1. Identifying and analyzing the key genes shared by papillary thyroid carcinoma and Hashimoto's thyroiditis using bioinformatics methods.
Liu TT; Yin DT; Wang N; Li N; Dong G; Peng MF
Front Endocrinol (Lausanne); 2023; 14():1140094. PubMed ID: 37324256
[TBL] [Abstract][Full Text] [Related]
2. Identification of
Zhang Y; Xie X; Zhou H; Li B; Ding L; Cai Z; Song H; Zhao S; Xu H
Front Endocrinol (Lausanne); 2023; 14():1131078. PubMed ID: 37455914
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer.
Liu C; Pan Y; Li Q; Zhang Y
Int J Med Sci; 2021; 18(15):3478-3487. PubMed ID: 34522174
[No Abstract] [Full Text] [Related]
4. Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto's thyroiditis.
Zhang Y; Tian Y
BMC Endocr Disord; 2022 Oct; 22(1):252. PubMed ID: 36266640
[TBL] [Abstract][Full Text] [Related]
5. Soluble DPP4 can act as a diagnostic biomarker in Hashimoto's thyroiditis with thyroid papillary carcinoma.
Zhang Y; Zhang Q; Zheng Y; Chen J; Liu N; Liu K; Song W
J Cancer Res Ther; 2023 Aug; 19(4):1048-1054. PubMed ID: 37675735
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Liu Y; Lv H; Zhang S; Shi B; Sun Y
Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
[TBL] [Abstract][Full Text] [Related]
7. Upregulation Of Protein Tyrosine Phosphatase Receptor Type C Associates To The Combination Of Hashimoto's Thyroiditis And Papillary Thyroid Carcinoma And Is Predictive Of A Poor Prognosis.
Wu Y; Han J; Vladimirovna KE; Zhang S; Lv W; Zhang Y; Jamaspishvili E; Sun J; Fang Q; Meng J; Qiao H
Onco Targets Ther; 2019; 12():8479-8489. PubMed ID: 31686862
[TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid carcinoma in children with Hashimoto's thyroiditis - a review of the literature between 2000 and 2020.
Sur ML; Gaga R; Lazăr C; Lazea C; Aldea C; Sur D
J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1511-1517. PubMed ID: 33180046
[TBL] [Abstract][Full Text] [Related]
9. Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis.
Subhi O; Schulten HJ; Bagatian N; Al-Dayini R; Karim S; Bakhashab S; Alotibi R; Al-Ahmadi A; Ata M; Elaimi A; Al-Muhayawi S; Mansouri M; Al-Ghamdi K; Hamour OA; Jamal A; Al-Maghrabi J; Al-Qahtani MH
PLoS One; 2020; 15(6):e0234566. PubMed ID: 32603365
[TBL] [Abstract][Full Text] [Related]
10. Integrative Analyses of Genes Associated with Hashimoto's Thyroiditis.
Qiu K; Li K; Zeng T; Liao Y; Min J; Zhang N; Peng M; Kong W; Chen LL
J Immunol Res; 2021; 2021():8263829. PubMed ID: 34493981
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Pathological Characteristics of Patients With Papillary Thyroid Carcinoma Coexisting With Hashimoto's Thyroiditis: A Retrospective Cohort Study.
Yang Y; Liu J; Shi X; Wang M
Cancer Control; 2023; 30():10732748231199647. PubMed ID: 37643366
[TBL] [Abstract][Full Text] [Related]
12. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
[TBL] [Abstract][Full Text] [Related]
13. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
[No Abstract] [Full Text] [Related]
14. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.
Zhang Y; Dai J; Wu T; Yang N; Yin Z
J Cancer Res Clin Oncol; 2014 Jun; 140(6):1021-6. PubMed ID: 24619663
[TBL] [Abstract][Full Text] [Related]
15. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
[TBL] [Abstract][Full Text] [Related]
16. Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis.
Xue G; Lin X; Wu JF; Pei D; Wang DM; Zhang J; Zhang WJ
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766727
[TBL] [Abstract][Full Text] [Related]
17. The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease.
Zhang L; Li H; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
BMC Cancer; 2012 Dec; 12():610. PubMed ID: 23256514
[TBL] [Abstract][Full Text] [Related]
18. Altered profile of glycosylated proteins in serum samples obtained from patients with Hashimoto's thyroiditis following depletion of highly abundant proteins.
Xu Y; Huo J; Nie R; Ge L; Xie C; Meng Y; Liu J; Wu L; Qin X
Front Immunol; 2023; 14():1182842. PubMed ID: 37457741
[TBL] [Abstract][Full Text] [Related]
19. Papillary thyroid cancer with Hashimoto's thyroiditis attenuates the tumour aggressiveness through the up-regulation of E-cadherin and TGF-β expression.
Kim SJ; Lee SE; Kim YI; Nam-Goong IS; Jung HW; Kim ES
Clin Exp Med; 2023 Jul; 23(3):833-840. PubMed ID: 35871446
[TBL] [Abstract][Full Text] [Related]
20. Interaction of BANCR in the relationship between Hashimoto's thyroiditis and papillary thyroid carcinoma expression patterns and possible molecular mechanisms.
Zhang J; Yao L; Guo Y
J Gene Med; 2024 Feb; 26(2):e3663. PubMed ID: 38342961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]